Cutaneous immune-related adverse events: incidence rates, risk factors and association with extracutaneous toxicity – a prospective study of 189 patients treated with checkpoint inhibitors at a Spanish tertiary care hospital
Article in Clinical and Experimental Dermatology (February 2024)